Ads
related to: g-protein-coupled receptors and cancer- EGFRm mNSCLC Progression
What's Next When Patients Progress
On EGFR-TKIs? Visit Site For Info.
- Addressing The Unmet Need
Learn About The Unmet Need For
Options That Can Improve Outcomes
- View Possible Approaches
See The Need For Additional Options
In EGFRm mNSCLC. Learn More.
- A New Line Of Thinking
For When EGFR-TKI Resistance Leads
To Progression in mNSCLC. Read More
- EGFRm mNSCLC Progression
Search results
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 1 week agoAmong abstracts announced yesterday by the American Society of Clinical Oncology (ASCO) is positive...
Artelo's (ARTL) FABP5 Inhibitor Effective in Pre-Clinical Study
Zacks via Yahoo Finance· 2 years agoArtelo Biosciencs ARTL were up 46% on Aug 16, during market hours, after the company announced...
FATE To End Janssen Deal and Prioritize Pipeline Development
Zacks via Yahoo Finance· 1 year agoFate Therapeutics, Inc. FATE announced that it has declined a proposal from Janssen Biotech, Inc., a...
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
Zacks via Yahoo Finance· 1 month agoIt was a busy week in the biotech sector with earnings reports from bigwigs Biogen BIIB and Bristol...
Q1 2024 Predictive Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 weeks agoParticipants Glenn Garmont; Investor Relations; LifeSci Venture Partners LP Raymond Vennare; Chairman of the Board, Chief Executive Officer; Predictive Oncology Inc Josh Blacher; Interim Chief ...
3 AI Stocks You’ll Regret Not Buying Soon
InvestorPlace via Yahoo Finance· 10 months agoArtificial intelligence (AI) will have a profound impact on the medical industry, where it could help accelerate drug discovery and patient treatment,...
2 “Strong Buy” Penny Stocks With Over 300% Upside on the Horizon
TipRanks via Yahoo Finance· 2 years agoFinding returns is the point of investing, it’s the path to profits and prosperity. But how to get...
AbCellera Biologics Inc. (ABCL) Q3 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. AbCellera Biologics Inc. (NASDAQ: ABCL)Q3 2022 Earnings CallNov 08,...
Ad
related to: g-protein-coupled receptors and cancer